title: Autoimmune haemolytic anaemia emerging during Campath treatment in a patient with CD5 negative chronic lymphocytic leukaemia.
abstract: Campath is being employed for the treatment of autoimmune haemolytic anemia (AIHA) whether or not associated to B cell chronic lymphoid leukaemia (CLL). CD5 negative CLL is relatively uncommon and runs an indolent course. We report a CD5 negative CLL patient who developed AIHA associated with cytomegalovirus infection reactivation whilst on treatment with Campath for progressive disease.
authors.affiliation: Department of Haematology, Inverclyde Royal Hospital, Larkfield Road, Greenock, PA16 0XN Scotland, UK ; Centre for Sports and Exercise Medicine, William Harvey Research Institute, Queen Mary University of London, 327 Mile End Rd, London, E1 4NS UK.
authors.forename: Paul R J
authors.initials: PR
authors.lastname: Ames
authors.affiliation: Department of Haematology, Inverclyde Royal Hospital, Larkfield Road, Greenock, PA16 0XN Scotland, UK.
authors.forename: Darren
authors.initials: D
authors.lastname: Aw
authors.affiliation: Department of Haematology, Inverclyde Royal Hospital, Larkfield Road, Greenock, PA16 0XN Scotland, UK.
authors.forename: Mervin G
authors.initials: MG
authors.lastname: Rainey
keywords: CMV; Campath; Haemolytic anemia; Lymphoid leukaemia